IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,729,628 | +4.4% | 162,559 | +3.2% | 0.01% | 0.0% |
| Q1 2023 | $1,656,942 | +97539.5% | 157,504 | +15.0% | 0.01% | 0.0% |
| Q4 2022 | $1,697 | -99.9% | 136,929 | -7.3% | 0.01% | 0.0% |
| Q3 2022 | $1,530,000 | -2.5% | 147,636 | +8.5% | 0.01% | 0.0% |
| Q2 2022 | $1,569,000 | -30.5% | 136,109 | -29.7% | 0.01% | -14.3% |
| Q4 2021 | $2,256,000 | -32.7% | 193,514 | -24.6% | 0.01% | -36.4% |
| Q3 2021 | $3,353,000 | +1.5% | 256,714 | -0.0% | 0.01% | 0.0% |
| Q2 2021 | $3,304,000 | +15.1% | 256,734 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $2,870,000 | – | 256,734 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |